© Reuters. FILE PHOTO: A company logo is seen at the AstraZeneca site in Macclesfield, Britain, May 11, 2021. REUTERS/Phil Noble
(Reuters) – AstraZeneca (NASDAQ:) on Thursday topped analysts’ expectations for third-quarter profit and sales, and raised its full-year adjusted earnings forecast.
Be the first to comment